Amlodipine/Valsartan/Hydrochlorothiazide Clonmel 10 mg/160 mg/25 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

amlodipine/valsartan/hydrochlorothiazide clonmel 10 mg/160 mg/25 mg film-coated tablets

clonmel healthcare ltd - amlodipine besilate; valsartan; hydrochlorothiazide - film-coated tablet - 10/160/25 milligram(s) - angiotensin ii antagonists, other combinations; valsartan, amlodipine and hydrochlorothiazide

Amlodipine/Valsartan/Hydrochlorothiazide Clonmel 10 mg/320 mg/25 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

amlodipine/valsartan/hydrochlorothiazide clonmel 10 mg/320 mg/25 mg film-coated tablets

clonmel healthcare ltd - amlodipine besilate; valsartan; hydrochlorothiazide - film-coated tablet - 10/320/25 milligram(s) - angiotensin ii antagonists, other combinations; valsartan, amlodipine and hydrochlorothiazide

Amlodipine/Valsartan/Hydrochlorothiazide Clonmel 5 mg/160 mg/12.5 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

amlodipine/valsartan/hydrochlorothiazide clonmel 5 mg/160 mg/12.5 mg film-coated tablets

clonmel healthcare ltd - amlodipine besilate; valsartan; hydrochlorothiazide - film-coated tablet - 5 mg/160 mg/12.5 milligram(s) - angiotensin ii antagonists, other combinations; valsartan, amlodipine and hydrochlorothiazide

Amlodipine/Valsartan/Hydrochlorothiazide Clonmel 5 mg/160 mg/25 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

amlodipine/valsartan/hydrochlorothiazide clonmel 5 mg/160 mg/25 mg film-coated tablets

clonmel healthcare ltd - amlodipine besilate; valsartan; hydrochlorothiazide - film-coated tablet - 5 mg/160 mg/25 milligram(s) - angiotensin ii antagonists, other combinations; valsartan, amlodipine and hydrochlorothiazide

Amlodipine / Valsartan Mylan European Union - English - EMA (European Medicines Agency)

amlodipine / valsartan mylan

mylan pharmaceuticals limited - amlodipine besilate, valsartan - hypertension - agents acting on the renin-angiotensin system - treatment of essential hypertension.amlodipine/valsartan mylan is indicated in adults whose blood pressure is not adequately controlled on amlodipine or valsartan monotherapy.

Valsartan/Hydrochlorothiazide Teva 80mg/12.5mg Film-coated Tablets Malta - English - Medicines Authority

valsartan/hydrochlorothiazide teva 80mg/12.5mg film-coated tablets

teva pharma b.v. swensweg 5, 2031 ga haarlem, netherlands - hydrochlorothiazide, valsartan - film-coated tablet - hydrochlorothiazide 80 mg valsartan 12.5 mg - agents acting on the renin-angiotensin system

Valsartan/Hydrochlorothiazide Teva 160mg/25mg Film-coated Tablets Malta - English - Medicines Authority

valsartan/hydrochlorothiazide teva 160mg/25mg film-coated tablets

teva pharma b.v. swensweg 5, 2031 ga haarlem, netherlands - hydrochlorothiazide, valsartan - film-coated tablet - hydrochlorothiazide 160 mg valsartan 25 mg - agents acting on the renin-angiotensin system

SEVIKAR HCT 40/5/25 olmesartan medoxomil 40 mg amlodipine (as besilate) 5 mg and hydrochlorothiazide 25 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

sevikar hct 40/5/25 olmesartan medoxomil 40 mg amlodipine (as besilate) 5 mg and hydrochlorothiazide 25 mg tablet blister pack

organon pharma pty ltd - olmesartan medoxomil, quantity: 40 mg; hydrochlorothiazide, quantity: 25 mg; amlodipine besilate, quantity: 6.944 mg (equivalent: amlodipine, qty mg) - tablet - excipient ingredients: microcrystalline cellulose; pregelatinised maize starch; croscarmellose sodium; magnesium stearate; colloidal anhydrous silica; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - sevikar hct is indicated for the treatment of hypertension, either as replacement for olmesartan medoxomil, amlodipine and hydrochlorothiazide being already taken as separate tablets or as add-on therapy where a patient's blood pressure is not controlled on a dual combination (see dosage and administration). this fixed dose combination is not indicated for initial therapy

SEVIKAR HCT 40/10/25 olmesartan medoxomil 40 mg amlodipine (as besilate) 10 mg and hydrochlorothiazide 25 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

sevikar hct 40/10/25 olmesartan medoxomil 40 mg amlodipine (as besilate) 10 mg and hydrochlorothiazide 25 mg tablet blister pack

organon pharma pty ltd - olmesartan medoxomil, quantity: 40 mg; amlodipine besilate, quantity: 13.888 mg/mg (equivalent: amlodipine, qty mg); hydrochlorothiazide, quantity: 25 mg - tablet - excipient ingredients: magnesium stearate; microcrystalline cellulose; croscarmellose sodium; pregelatinised maize starch; colloidal anhydrous silica; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350 - sevikar hct is indicated for the treatment of hypertension, either as replacement for olmesartan medoxomil, amlodipine and hydrochlorothiazide being already taken as separate tablets or as add-on therapy where a patient's blood pressure is not controlled on a dual combination (see dosage and administration). this fixed dose combination is not indicated for initial therapy

SEVIKAR HCT 20/5/12.5 olmesartan medoxomil 20 mg amlodipine (as besilate) 5 mg and hydrochlorothiazide 12.5mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

sevikar hct 20/5/12.5 olmesartan medoxomil 20 mg amlodipine (as besilate) 5 mg and hydrochlorothiazide 12.5mg tablet blister pack

organon pharma pty ltd - olmesartan medoxomil, quantity: 20 mg; amlodipine besilate, quantity: 6.944 mg (equivalent: amlodipine, qty mg); hydrochlorothiazide, quantity: 12.5 mg - tablet - excipient ingredients: microcrystalline cellulose; magnesium stearate; pregelatinised maize starch; croscarmellose sodium; colloidal anhydrous silica; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - sevikar hct is indicated for the treatment of hypertension, either as replacement for olmesartan medoxomil, amlodipine and hydrochlorothiazide being already taken as separate tablets or as add-on therapy where a patient's blood pressure is not controlled on a dual combination (see dosage and administration). this fixed dose combination is not indicated for initial therapy